Cargando…
SAT587 Methylation-based Machine Learning Classifiers Discriminate Sellar Tumors By Lobe Origin Using Liquid Biopsy Or Surgical Specimens
Disclosure: G.A. Herrgott: None. K.P. Asmaro: None. M. Wells: None. K. Nelson: None. B. Thomas: None. L.A. Hasselbach: None. A. Transou: None. S. Cazacu: None. K.M. Tundo: None. S. Nadimidla: None. L. Scarpace: None. J. Barnholtz-Sloan: None. A.E. Sloan: None. W.R. Selman: None. A.C. deCarvalho: Non...
Autores principales: | Herrgott, Grayson A, Asmaro, Karam P, Wells, Michael, Nelson, Kevin, Thomas, Bartow, Hasselbach, Laura A, Transou, Andrea, Cazacu, Simona, Tundo, Kelly M, Nadimidla, Sudha, Scarpace, Lisa, Barnholtz-Sloan, Jill, Sloan, Andrew E, Selman, Warren R, deCarvalho, Ana C, Mukherjee, Abir, Robin, Adam M, Lee, Ian Y, Craig, John, Kalkanis, Steven, Snyder, James, Walbert, Tobias, Rock, Jack, Noushmehr, Houtan, Barros Castro, Ana Valeria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554469/ http://dx.doi.org/10.1210/jendso/bvad114.1320 |
Ejemplares similares
-
ODP653 DNA Methylation Markers Detected in Liquid Biopsy Specimens Differentiate Pituitary Neuroendocrine Tumors from Other Sellar and CNS Diseases
por: Castro, Ana Valeria, et al.
Publicado: (2022) -
Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors
por: Herrgott, Grayson A, et al.
Publicado: (2022) -
OTME-5. Meningioma liquid biopsy specimens exhibit contrasting immune-cell landscapes across methylation-subtypes and estimated recurrence risk subgroups
por: Herrgott, Grayson, et al.
Publicado: (2021) -
Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas
por: Herrgott, Grayson A., et al.
Publicado: (2023) -
Noninvasive approaches to detect methylation-based markers to monitor gliomas
por: Noushmehr, Houtan, et al.
Publicado: (2022)